Biotech & Health

Investors are betting big on startups like Inceptive that are merging biotech and AI. This funding round triples Inceptive's valuation to over $300 million since it's $20M seed round in 2021.

Not only does the implant use Ann's brain signals to generate speech, but it also animates a digital avatar with facial expressions, mimicking the natural nuances of human communication.

The oversubscribed round was co-led by an undisclosed U.S. life sciences investor and returning lead investor Andreessen Horowitz.

Learn about the groundbreaking impact of generative AI in healthcare, including faster drug discovery, more accurate diagnosis, personalized treatment, and efficient operations.